Eckert & Ziegler SE (ISIN DE0005659700), a world-leading specialist in isotope-related components, equipment and services for nuclear medicine and radiation therapy, today signed a collaboration and supply agreement with Thor Medical, a leading…
Different types of bone marrow stem cells give rise to blood and immune cells. A team led by Simon Haas now reports in “Nature Cell Biology” how that diversity develops. The findings could help improve stem cell therapies, including treatments for…
Stiftung Charité is providing EUR 900,000 to support Charité’s new Profile Partnerships Program, part of the university hospital’s Internationalization Strategy 2030.
Lucid Genomics’ tertiary pipeline is validated for the interpretation of data generated using Oxford Nanopore sequencing.
Strategic Initiative Strengthens Berlin as Europe’s Hub of Digital Cardiology
Charité study collates global therapeutic experiences for the first time
Groundbreaking discovery of antimicrobial peptides in ant venom has far-reaching implications
In “Nature Communications,” Max Delbrück Center researchers show how immune cells initiate zebrafish heart regeneration, highlighting the possibility that precisely timed inflammatory signaling of specific immune cells — rather than broad…
On April, 22th, the BeCAT and Si-M were inaugurated in Berlin—two important beacons for our region. What they share is the goal of developing effective personalized therapies for diseases that have so far been considered incurable.
16.-20.11.2026 | Anmeldeschluss 30.06.2026
